ProQR Therapeutics N.V. buy Oppenheimer Holdings Inc.
Start price
13.05.25
/
50%
€1.38
Target price
13.05.26
€8.10
Performance (%)
15.13%
Price
13.03.26
€1.45
Summary
This prediction is currently active. The prediction currently has a performance of 15.13%. This prediction currently runs until 13.05.26. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| ProQR Therapeutics N.V. | -4.164% | -4.164% |
| iShares Core DAX® | -1,10 % | -6,08 % |
| iShares Nasdaq 100 | 0,33 % | 2,33 % |
| iShares Nikkei 225® | -1,08 % | -7,99 % |
| iShares S&P 500 | -0,06 % | 0,88 % |
Comments by Oppenheimer_Holdings for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (NASDAQ: PRQR) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $15.00 to $9.00. They now have an "outperform" rating on the stock.
Ratings data for PRQR provided by MarketBeat
Stopped prediction by Oppenheimer_Holdings for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.51
12.03.26
12.03.26
€7.80
12.03.27
12.03.27
5.51%
13.03.26
13.03.26
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€2.36
10.01.25
10.01.25
€14.62
10.01.26
10.01.26
-37.64%
11.01.26
11.01.26